Amino Acids, Peptides, and Proteins: News and Research on Membrane Proteins

MeSH tree: D12.776.543

FDA approves first-in-class drug for polycythemia vera

The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.

How wildfire smoke may contribute to neurodegenerative diseases

Researchers at Barrow Neurological Institute in Phoenix have uncovered how wildfire smoke may trigger harmful inflammation in the brain, offering new insight into why prolonged smoke exposure has been associated with neurological ...

Experimental drug may disrupt immune circuits in pneumonia

A drug that blocks calcium release-activated calcium (CRAC) channels may help interrupt harmful immune cell interactions that drive severe viral pneumonia, according to a new study published in The Journal of Clinical Investigation. ...

page 2 from 40